Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Rectal Neoplasms × Metronidazole × Clear all

Phase

Status

Recruiting 2 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Pancreatic Neoplasms 1 Anastomotic Leak 1

Interventions

Fluorouracil 11 Oxaliplatin 10 Leucovorin 10 Capecitabine 7 Irinotecan 6 Radiotherapy 4 Bevacizumab 4 regorafenib 2 aflibercept 2 Reverse Transcriptase Polymerase Chain Reaction 2 Radiation 2 Neoadjuvant Therapy 2 tucatinib 1 trifluridine tipiracil drug combination 1 trastuzumab biosimilar HLX02 1 sulindac sulfone 1 sargramostim 1 pembrolizumab 1 lonafarnib 1 irofulven 1 infigratinib 1 dehydroftorafur 1 XELOX 1 Trifluridine 1 Trastuzumab 1 Transplantation 1 Sunitinib 1 Sodium Chloride 1 Sigmoidoscopy 1 Saline Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02682485 2023-04-26

SES-DTA

University of Chicago

Phase 2 Withdrawn

Gastrointestinal

Rectal Neoplasms, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon ⚡